Screener
Core Laboratories CLB Operating Income
Operating Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Core Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Core Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 6:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-198109
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Depreciation | 3,556 | 3,593 |
| Amortization | 208 | 124 |
| Other (income) expense, net | (645) | 2,335 |
| OPERATING INCOME | 1,887 | 4,417 |
| Interest expense | 2,891 | 2,602 |
| Income (loss) before income taxes | (1,004) | 1,815 |
| Income tax expense (benefit) | (251) | 1,746 |
| Net income (loss) | (753) | 69 |
Item 1. Financial Statements
FAQ
- What is Core Laboratories's operating income?
- Core Laboratories (CLB) reported operating income of $1.89M in Q1 2026.
- How has Core Laboratories's operating income changed year-over-year?
- Core Laboratories's operating income decreased by 57.3% year-over-year, from $4.42M to $1.89M.
- What is the long-term trend for Core Laboratories's operating income?
- Over 4 years (2021 to 2025), Core Laboratories's operating income has grown at a 5.7% compound annual growth rate (CAGR), from $45.26M to $56.47M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Core Laboratories's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude